Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-25-009121
Filing Date
2025-06-12
Accepted
2025-06-12 13:59:05
Documents
1
Period of Report
2025-06-11

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-69481.html 4  
1 PRIMARY DOCUMENT marketforms-69481.xml 4 4139
  Complete submission text file 0001214659-25-009121.txt   5658
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Issuer) CIK: 0001398733 (see all company filings)

EIN.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O GAMIDA CELL LTD. 116 HUNTINGTON AVENUE BOSTON MA 02116
Business Address
Jenkins Abigail L. (Reporting) CIK: 0001947032 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38599 | Film No.: 251042404